150 related articles for article (PubMed ID: 29723355)
1. Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience.
Gibbons IL; Sonagli M; Bertolli E; Macedo MP; Pinto CAL; Duprat Neto JP
An Bras Dermatol; 2018 Mar; 93(2):299-301. PubMed ID: 29723355
[TBL] [Abstract][Full Text] [Related]
2. Topical diphencyprone immunotherapy for cutaneous metastatic melanoma.
Damian DL; Shannon KF; Saw RP; Thompson JF
Australas J Dermatol; 2009 Nov; 50(4):266-71. PubMed ID: 19916970
[TBL] [Abstract][Full Text] [Related]
3. Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone.
Damian DL; Thompson JF
J Am Acad Dermatol; 2007 May; 56(5):869-71. PubMed ID: 17276544
[TBL] [Abstract][Full Text] [Related]
4. Congenital malignant melanoma and cutaneous metastases treated with diphencyprone.
Fawcett JM; Newell EL; Kennedy CT
Clin Exp Dermatol; 2016 Mar; 41(2):212-3. PubMed ID: 26053880
[No Abstract] [Full Text] [Related]
5. Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment.
Gulati N; Carvajal RD; Postow MA; Wolchok JD; Krueger JG
Exp Dermatol; 2016 Jul; 25(7):553-4. PubMed ID: 27061281
[No Abstract] [Full Text] [Related]
6. Topical diphencyprone immunotherapy for a large primary melanoma on an elderly leg.
Damian DL; Thompson JF
Am J Clin Dermatol; 2011 Dec; 12(6):403-4. PubMed ID: 21967115
[No Abstract] [Full Text] [Related]
7. Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre study.
Read T; Webber S; Tan J; Wagels M; Schaider H; Soyer HP; Smithers BM
J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2030-2037. PubMed ID: 28626861
[TBL] [Abstract][Full Text] [Related]
8. Topical diphencyprone for the treatment of locoregional intralymphatic melanoma metastases of the skin; the 5-year Norwich experience.
Moncrieff M; Fadhil M; Garioch J
Br J Dermatol; 2016 May; 174(5):1141-2. PubMed ID: 26598951
[No Abstract] [Full Text] [Related]
9. Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series.
Yeung C; Petrella TM; Wright FC; Abadir W; Look Hong NJ
Expert Rev Clin Immunol; 2017 Apr; 13(4):383-388. PubMed ID: 28121191
[TBL] [Abstract][Full Text] [Related]
10. Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma.
Damian DL; Saw RP; Thompson JF
J Surg Oncol; 2014 Mar; 109(4):308-13. PubMed ID: 24522938
[TBL] [Abstract][Full Text] [Related]
11. Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study.
Read T; Webber S; Thomas J; Wagels M; Schaider H; Soyer HP; Smithers BM
BMJ Open; 2017 Oct; 7(10):e016816. PubMed ID: 28988173
[TBL] [Abstract][Full Text] [Related]
12. Response rates of cutaneous melanoma metastases to diphencyprone: A meta-analysis.
Lôbo MM; Calsavara VF; Ricci BV; Lopes Pinto CA; Bertolli E; Duprat Neto JP
J Am Acad Dermatol; 2020 Dec; 83(6):1812-1813. PubMed ID: 32289400
[No Abstract] [Full Text] [Related]
13. Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine.
Harland CC; Saihan EM
Lancet; 1989 Aug; 2(8660):445. PubMed ID: 2569622
[No Abstract] [Full Text] [Related]
14. [In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
Elfatoiki FZ; Longvert C; Clerici T; Bourgault-Villada I; Roudier-Pujol C; Vasseur E; Saiag P
Ann Dermatol Venereol; 2014 Feb; 141(2):106-10. PubMed ID: 24507204
[TBL] [Abstract][Full Text] [Related]
15. [Experience in the treatment of cutaneous in-transit melanoma metastases and satellitosis with intralesional interleukin-2].
Dehesa LA; Vilar-Alejo J; Valerón-Almazán P; Carretero G
Actas Dermosifiliogr; 2009 Sep; 100(7):571-85. PubMed ID: 19715642
[TBL] [Abstract][Full Text] [Related]
16. Sequencing in management of in-transit melanoma metastasis: Diphencyprone versus isolate limb infusion.
Lo MC; Garioch J; Moncrieff MD
J Plast Reconstr Aesthet Surg; 2020 Jul; 73(7):1263-1267. PubMed ID: 32245735
[TBL] [Abstract][Full Text] [Related]
17. Complete remission of extensive cutaneous metastatic melanoma on the scalp under topical mono-immunotherapy with diphenylcyclopropenone.
Hinz T; Ehler LK; Bieber T; Schmid-Wendtner MH
Eur J Dermatol; 2013; 23(4):532-3. PubMed ID: 24002471
[No Abstract] [Full Text] [Related]
18. Efficacy of topical diphencyprone for melanoma in-transit metastases: a systematic review and meta-analysis.
Pham JP; Dwyer L; Phan K; Menzies AM; Frew JW
Melanoma Res; 2023 Oct; 33(5):434-436. PubMed ID: 37650727
[No Abstract] [Full Text] [Related]
19. Successful treatment of in-transit melanoma metastases using topical 2-4 dinitrochlorobenzene.
von Nida J; Quirk C
Australas J Dermatol; 2003 Nov; 44(4):277-80. PubMed ID: 14616496
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases.
Radny P; Caroli UM; Bauer J; Paul T; Schlegel C; Eigentler TK; Weide B; Schwarz M; Garbe C
Br J Cancer; 2003 Nov; 89(9):1620-6. PubMed ID: 14583759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
